ATE356212T1 - O-fukosyltransferase - Google Patents

O-fukosyltransferase

Info

Publication number
ATE356212T1
ATE356212T1 AT97953303T AT97953303T ATE356212T1 AT E356212 T1 ATE356212 T1 AT E356212T1 AT 97953303 T AT97953303 T AT 97953303T AT 97953303 T AT97953303 T AT 97953303T AT E356212 T1 ATE356212 T1 AT E356212T1
Authority
AT
Austria
Prior art keywords
fukosyl
transferase
characterization
purification
identification
Prior art date
Application number
AT97953303T
Other languages
English (en)
Inventor
Yang Wang
Michael W Spellman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/978,741 external-priority patent/US6100076A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE356212T1 publication Critical patent/ATE356212T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT97953303T 1997-01-31 1997-12-17 O-fukosyltransferase ATE356212T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79249897A 1997-01-31 1997-01-31
US08/978,741 US6100076A (en) 1997-01-31 1997-11-26 O-fucosyltransferase

Publications (1)

Publication Number Publication Date
ATE356212T1 true ATE356212T1 (de) 2007-03-15

Family

ID=27121286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97953303T ATE356212T1 (de) 1997-01-31 1997-12-17 O-fukosyltransferase

Country Status (10)

Country Link
US (1) US6270987B1 (de)
EP (1) EP0942992B1 (de)
JP (1) JP3394540B2 (de)
AT (1) ATE356212T1 (de)
AU (1) AU729158B2 (de)
CA (1) CA2277266A1 (de)
DE (1) DE69737457T2 (de)
DK (1) DK0942992T3 (de)
ES (1) ES2283033T3 (de)
WO (1) WO1998033924A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060105444A1 (en) * 1997-01-31 2006-05-18 Genentech, Inc. O-fucosyltransferase
EP1187908A4 (de) * 1999-06-11 2003-09-10 Human Genome Sciences Inc 42 humane sekretierte proteine
NZ525380A (en) 2000-09-18 2008-06-30 Biogen Idec Inc Non-fucosylated forms of Cripto and their use as tumor blocking agents
WO2005055944A2 (en) 2003-12-05 2005-06-23 Cincinnati Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
CA2757169A1 (en) 2009-04-13 2010-10-21 Children's Hospital Medical Center Milk oligosaccharide compositions and use thereof in treating infection in animals
ES2651067T3 (es) 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
SG11201408538PA (en) 2012-07-13 2015-02-27 Roche Glycart Ag Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseases
EP3288389A4 (de) 2015-04-28 2018-10-10 Children's Hospital Medical Center Verwendung von oligosaccharidzusammensetzungen zur verstärkung der gewichtszunahme
DK179801B1 (en) * 2017-12-17 2019-06-26 Upfront Chromatography A/S SEPARATION OF OLIGOSACCHARIDES

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3691016A (en) 1970-04-17 1972-09-12 Monsanto Co Process for the preparation of insoluble enzymes
CA1023287A (en) 1972-12-08 1977-12-27 Boehringer Mannheim G.M.B.H. Process for the preparation of carrier-bound proteins
GB1479268A (en) 1973-07-05 1977-07-13 Beecham Group Ltd Pharmaceutical compositions
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US3959642A (en) 1975-02-06 1976-05-25 Lawrence Peska Associates, Inc. Incense lamp
US4195128A (en) 1976-05-03 1980-03-25 Bayer Aktiengesellschaft Polymeric carrier bound ligands
US4330440A (en) 1977-02-08 1982-05-18 Development Finance Corporation Of New Zealand Activated matrix and method of activation
CA1093991A (en) 1977-02-17 1981-01-20 Hideo Hirohara Enzyme immobilization with pullulan gel
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4229537A (en) 1978-02-09 1980-10-21 New York University Preparation of trichloro-s-triazine activated supports for coupling ligands
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
JPS57500445A (de) 1980-03-21 1982-03-11
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4965199A (en) 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
EP0206448B1 (de) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
WO1987005330A1 (en) 1986-03-07 1987-09-11 Michel Louis Eugene Bergh Method for enhancing glycoprotein stability
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
EP0321196A3 (de) 1987-12-18 1990-07-18 Mycogen Plant Science, Inc. Transkriptionsaktivator des 780 T-DNA-Gens
US5108901A (en) 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
ATE135397T1 (de) 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
EP0402226A1 (de) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformationsvektoren für Hefe Yarrowia
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
EP0502036B1 (de) 1989-11-22 1995-12-20 Genentech, Inc. Latenz assoziierte peptide und deren verwendung
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof

Also Published As

Publication number Publication date
JP3394540B2 (ja) 2003-04-07
WO1998033924A1 (en) 1998-08-06
DE69737457D1 (de) 2007-04-19
EP0942992A1 (de) 1999-09-22
AU729158B2 (en) 2001-01-25
CA2277266A1 (en) 1998-08-06
ES2283033T3 (es) 2007-10-16
EP0942992B1 (de) 2007-03-07
DE69737457T2 (de) 2007-11-29
JP2001527389A (ja) 2001-12-25
AU5707798A (en) 1998-08-25
DK0942992T3 (da) 2007-07-02
US6270987B1 (en) 2001-08-07

Similar Documents

Publication Publication Date Title
MXPA02004666A (es) Gelatinas recombinantes.
DK0850307T3 (da) Alkalifile og termofile mikroorganismer og enzymer, der opnås derfra
BR0012759A (pt) Neurotoxinas recombinantes ativáveis
DE69739665D1 (de) Isoliertes, dimerisches fibroblasten-aktivierendes protein alpha und anwendungen desselben
ATE317441T1 (de) Cathepsin-02-protease
BR9810870A (pt) Regulação de expressão de quinolato fosforibosil transferase
MY113489A (en) Reversible protease inhibitors
AU144678S (en) Bottle
ZA982568B (en) The specificity of gene expression.
DK1342718T3 (da) N-alkylerede ureider
DE69532033D1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
ATE356212T1 (de) O-fukosyltransferase
DE69634077D1 (de) Haemophilus adhäsionsproteinen
MX9806041A (es) Proteina purificada sr-p70.
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
BG101787A (en) Aprotinine options having improved properties
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
ATE321143T1 (de) Genexpression in monocyten und makrophagen
WO2000043525A3 (en) Metalloproteinase-disintegrin family members: svph dnas and polypeptides
DK1141337T3 (da) Gram-positive bakterier, som mangler HtrA-proteaseaktivitet, samt deres anvendelser
ATE311440T1 (de) Bacillus-proteasen
BR9803717A (pt) ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase.
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
ATE313624T1 (de) Bacillus proteasen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0942992

Country of ref document: EP

REN Ceased due to non-payment of the annual fee